A-Viral's RA-study has good progress, Management talks with major Pharmaceuticals and Biotech Investors
29-Jun-2004 -
A-Viral's phase 2 study on RA is progressing well, and has attracted attention from several of the world's major pharmaceutical companies, who has asked for meetings to evaluate our technology. Also biotech investors ask for presentations.
The study on Rheumatoid Arthritis at Jan van Breemen's ...
autoimmune diseases
rheumatoid arthritis